EFB Dengue Literature Review

Type I Interferon

6 min read

Type I Interferon

Overview

Type I interferons (IFNα, IFNβ) are the dominant innate cytokine class in acute dengue and are repeatedly implicated in the atypical B cell literature — but almost always as a correlate rather than a tested driver. This page keeps that distinction visible, because the temptation to treat “type I IFN signature” as equivalent to “IFN-γ-driven DN2 programme” is strong and currently unsupported.

Background context (not sourced to an ingested paper): type I IFNs signal through IFNAR1/IFNAR2 and the ISGF3 complex (STAT1/STAT2/IRF9).

Key Points from Literature

In dengue, type I IFN dominates the early response

In the atypical B cell literature, type I IFN is a correlate

★ The untested substitution question

  • Zumaquero2019 - IFN-gamma Programs T-bet-hi B Cells for ASC Differentiation notes considerable overlap between IFNα- and IFN-γ-regulated genes and proposes that IFNα and IFN-γ “may augment TLR7 signaling in human B cells by similar mechanisms.” It cites prior work that IFNα-directed signals enhance TLR7-mediated human B cell differentiation.
  • No ingested source has tested whether type I IFN can substitute for IFN-γ in the priming window that generates T-bet^hi^ pre-ASCs. This is the single most important open question for transferring the DN2 model into dengue, whose early cytokine environment is type-I-dominated rather than IFN-γ-dominated.

Where the dengue IFN-α actually comes from, and what it costs to make

This section addresses the upstream half — what produces type I IFN in dengue. It does not bear on the substitution question above, which concerns what type I IFN does to a B cell. If anything it sharpens that question by establishing that the IFN-α is genuinely there and genuinely TLR7-driven.

  • ★ Dengue-driven IFN-α from human Plasmacytoid Dendritic Cells is TLR7-dependent. Live dengue-2 virus induced IFN-α from purified human pDCs, and that response was significantly reduced by the TLR7 antagonist IRS 661 (p < 0.02) alongside influenza and R-848 (see Wang2006 - Flavivirus Activation of pDCs and TLR7 Signaling, in vitro, n=4 independent experiments). Mean absolute output by stimulus alone: D2V (MOI 2.5) 948 pg/ml, influenza X31 (MOI 0.25) 29,490 pg/ml, R-848 (1 µM) 18,381 pg/ml, CpG 2336 53,864 pg/ml. ⚠ Do not compare these against the same paper’s other figure — D2V is MOI 10 there (27,751 pg/ml). Within a single experiment, dengue needed ~50× the MOI of influenza for the same order of IFN-α.
  • ★ The type I IFN arm of TLR7 has a higher activation threshold than the NF-κB→IL-8 arm. In a TLR Reporter Cell Assay the two arms dissociated cleanly: short synthetic RNAs triggered neither, R-848 and poly(U) triggered NF-κB/IL-8 but no type I IFN, and only genomic viral RNAs triggered both (see Wang2006 - Flavivirus Activation of pDCs and TLR7 Signaling, in vitro, one representative experiment of four).
  • ★ But the threshold is a property of the cell, not the ligand — and pDCs are built to clear it. Primary pDCs made 13,694–18,381 pg/ml IFN-α to R-848, the same agonist that produced none in the reporter line. The authors attribute this to pDCs’ higher abundance of limiting downstream components, naming IRF-7 (qRT-PCR “data not shown”). The dose–response shape differs accordingly: transfected influenza vRNA gave an inverted-U response in the reporter line but a log-linear one in pDCs, which the authors read as evidence for receptor multimerization (see Wang2006 - Flavivirus Activation of pDCs and TLR7 Signaling). Where B cells sit on this limiting-component axis is unknown — no ingested source measures B cell IRF7 or type I IFN output.
  • Attributed context, not ingested: a blunted blood pDC response to acute systemic viral infection is reported to associate with increased dengue disease severity (Pichyangkul et al. 2003, J Immunol 171:5571, cited as ref 5 in Wang2006 - Flavivirus Activation of pDCs and TLR7 Signaling — not ingested, queued). If it holds, it points the opposite way from a simple “type I IFN drives pathology” reading.

Contradictions & Debates

Correlate or driver? Every type I IFN claim in this wiki is correlational or pathway-predicted. The one place a direct comparison exists — Jenks2018 - DN2 B Cells and EF Pathway in SLE — found the type I IFN association only “modest” while the TLR7 mechanism was demonstrated experimentally. The wiki should not describe type I IFN as a driver of DN2 formation.

Does the dengue IFN environment prime the DN2 pathway? Unknown, and consequential. If type I IFN substitutes for IFN-γ, the dengue innate response would be expected to prime DN2 formation; if it does not, the dengue DN2 signal must come from somewhere else. See IFN-gamma Contradictions.

IFN-gamma, TLR7, CXCR3, T-bet, Inflammatory Monocyte, Plasmacytoid Dendritic Cell, Toll-like Receptor Signaling in B Cells, DN2 B Cell, Antibody-Dependent Enhancement, TLR Reporter Cell Assay, ELISA

Sources

Graph View

Backlinks